← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1543)
- Tyro3 and Gas6 are associated with white matter and myelin integrity in multiple sclerosis. (2024/12/13) ♡
- Signatures of chronic pain in multiple sclerosis: a machine learning approach to investigate trigeminal neuralgia. (2024/12/13) ♡
- Dysphagia in multiple sclerosis: pathophysiology, assessment, and management-an overview. (2024/12/13) ♡
- Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis. (2024/12/12) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Azathioprine for people with multiple sclerosis. (2024/12/09) ♡
- Acceptability and Feasibility of the English Version of Elevida, a Self-Guided Online Fatigue Intervention for People With Multiple Sclerosis. (2024/12/09) ♡
- Relationship Between T-helper 1 Inflammatory Biomarkers and Hematological Index Responses in Patients With Multiple Sclerosis. (2024/12/07) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Comparative efficacy and tolerability of ublituximab vs. other monoclonal antibodies in the treatment of relapsing multiple sclerosis: a systematic review and network meta-analysis of randomized trials. (2024/12/06) ♡
- P2X (7)-receptor binding in new-onset and secondary progressive MS - a [(11)C]SMW139 PET study. (2024/12/05) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Neuroimaging markers and disability scales in multiple sclerosis: A systematic review and meta-analysis. (2024/12/05) ♡
- Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trial. (2024/12/05) ♡
- Evaluating multiple sclerosis severity loci 30 years after a clinically isolated syndrome. (2024/12/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Co-Existent Central and Peripheral Demyelination: Related or Coincidental? (2024/12/03) ♡
- A data-driven model of disability progression in progressive multiple sclerosis. (2024/12/03) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Idiopathic Multiple Localized Lipoatrophy Mimicking Amyotrophic Lateral Sclerosis. (2024/12/01) ♡
- Analysis of Immunological Memory for John Cunningham Virus in a Mexican Population of Patients with Multiple Sclerosis Under Treatment. (2024/11/29) ♡
- Alexithymia and attachment on mental health of people with multiple sclerosis: The mediating role of perceived social support and loneliness. (2024/11/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. New-Onset Multiple Sclerosis in Pregnancy: Diagnostic Approaches and Treatment Dilemmas. (2024/11/28) ♡
- Patterns and predictors of multiple sclerosis phenotype transition. (2024/11/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Concomitant Amyotrophic Lateral Sclerosis and Rheumatoid Arthritis: A Case Report. (2024/11/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Relevance of Saliva Analyses in Terms of Etiological Factors, Biomarkers, and Indicators of Disease Course in Patients with Multiple Sclerosis-A Review. (2024/11/22) ♡
- Smartphone Postural Sway and Pronator Drift tests as Measures of Neurological Disability. (2024/11/21) ♡
- Barriers for work in people with multiple sclerosis: a Norwegian cultural adaptation and validation of the short version of the multiple sclerosis work difficulties questionnaire. (2024/11/20) ♡
- A Clinical Care Algorithm for Detecting Progression in Multiple Sclerosis: RetratEMos Project. (2024/11/19) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial. (2024/11/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Beyond the Stroke: A Case Report of Multiple Sclerosis. (2024/11/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pericardial Effusion as a Presentation of Lymphangioleiomyomatosis. (2024/11/10) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. What Is New and Effective in Treating Refractory Trigeminal Neuralgia? (2024/11/06) ♡
- The Fibrotic Response in Pericyte Culture Upon Exposure to Multiple Sclerosis Sera. (2024/11/03) ♡
- Brain hemodynamic responses and fall prediction in older adults with multiple sclerosis. (2024/11/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Immature Smooth Muscle Infiltration in Sporadic Lymphangioleiomyomatosis: A Case Study. (2024/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Increased central obesity correlates with physical activity and food processing in recently diagnosed multiple sclerosis. (2024/10/01) ♡
- Associations between fatigue impact and physical and neurobehavioural factors: An exploration in people with progressive multiple sclerosis. (2024/10/01) ♡
- Serum Vitamin D3 as a Potential Biomarker for Neuronal Damage in Smoldering Multiple Sclerosis. (2024/09/29) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Olig2(+) single-colony-derived cranial bone-marrow mesenchymal stem cells achieve improved regeneration in a cuprizone-induced demyelination mouse model. (2024/09/25) ♡
- [Effectiveness and tolerance of azathioprine as first-line treatment for multiple sclerosis: a case study from Morocco]. (2024/09/18) ♡
- Annexin A1, calreticulin and high mobility group box 1 are elevated in secondary progressive multiple sclerosis: Does immunogenic cell death occur in multiple sclerosis? (2024/09/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autoimmune Diseases Following Environmental Disasters: A Narrative Review of the Literature. (2024/09/04) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Long-term demyelination and aging-associated changes in mice corpus callosum; evidence for the role of accelerated aging in remyelination failure in a mouse model of multiple sclerosis. (2024/09/01) ♡
- Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis. (2024/08/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Analysis of the Influence of Depression on the Occupational Performance of People Diagnosed with Multiple Sclerosis and Its Impact on Caregiver Burden. (2024/08/09) ♡
- Circulating proteomic biomarkers for diagnosing sporadic amyotrophic lateral sclerosis: a cross-sectional study. (2024/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction. (2024/08/01) ♡
- Mediterranean diet and associations with the gut microbiota and pediatric-onset multiple sclerosis using trivariate analysis. (2024/07/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The effect of interferon beta on quality of life in patients with multiple sclerosis: A systematic review and meta-analysis study. (2024/07/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Electrical storm following pregnancy in systemic scleroderma: A case report. (2024/07/01) ♡
- Life space assessment and falls in older adults with multiple sclerosis. (2024/07/01) ♡
- The Use of Traditional and Complementary Medicine Among Patients With Multiple Sclerosis in Morocco. (2024/06/05) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.